Skip to main content
Blog-Article-Page-header

Blogs

Digitize Instructions for Use (IFU) to Comply with EU MDR

The regulation brings digital enablement to the forefront, compelling electronic instructions for use. EU MDR is turning digitization on its head. This new regulation, which goes into effect Ma…

Clinical projects (you or your vendors/CROs) are putting them at Risk by 80%…

20% of risks are addressed by teams in clinical projects. 30% of the risks or either siloed or trapped in functions. 50% A vast majority (50%) are unreported and lost. If you kno…

Why Combining Performance, Oversight, Risk and Compliance are very important for your Clinical Development?

Unfortunately, most sponsors and CROs use multiple applications to manage their clinical studies. Integrating multiple applications may be challenging for example reporting through multiple ap…

Why sponsors should opt Configurable IRT system, before opting any custom version?

Clinical trials are more complex than ever and a robust, reliable & cost efficient clinical supply strategy is vital more than ever before. The number and complexity of issues affecting supply…

Are You Aware of Other Countrie’s Regulatory Requirements?

To enter into a market, biopharmaceutical companies should have information of local regulations irrespective of the type of drug. Tracking the local regulations of semi and non-regulated markets …

CONNECT WITH US

    Subscribe
    The First Step

    Let's talk about how DDi can help you